An official website of the United States Government —

Here’s how you know

Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Advising the Congress on Medicare issues
MedPAC > Recommendations

Commission Recommendations

MedPAC makes recommendations to the Congress and to the Secretary of Health and Human Services on issues affecting the administration of the Medicare program. With its recommendations, the Commission strives to improve the delivery of care, while ensuring financial stability and maximizing value for the program. After extensive analysis and evaluation, our recommendations are discussed and voted on by Commissioners in our public meetings. Recommendations are typically published in two main reports, released in March and June of each year.

Recommendations Topic(s) Publication

Addressing health care errors under Medicare (E)

The Secretary should work with providers and other stakeholders to identify and promote effective and efficient processes, structures, and activities for reducing preventable errors and to set progressive targets for improvement in patient safety through Medicare’s quality improvement programs.

  • Quality

June 1999 - Chapter 3

Addressing health care errors under Medicare (F)

The Secretary should not establish requirements that specify maximum tolerance rates of errors in health care delivery under Medicare’s conditions of participation for health care providers.

  • Quality

June 1999 - Chapter 3

Addressing health care errors under Medicare (G)

The Secretary should fund research to study appropriate use of autopsies and to evaluate approaches for using information derived from autopsies in health care quality improvement and error-reduction initiatives.

  • Quality

June 1999 - Chapter 3

Improving care at the end of life (A)

Make end-of-life care a national quality improvement priority for Medicare+Choice and traditional Medicare.

  • Part C (Medicare Advantage)
  • Quality

June 1999 - Chapter 7

Improving care at the end of life (B)

Support research on care at the end of life, and work with nongovernmental organizations as they (1) educate the health care profession and the public about care at the end of life, and (2) develop measures to accredit health care organizations and provide public accountability for the quality of end-of-life care.

  • Quality

June 1999 - Chapter 7

Improving care at the end of life (C)

Sponsor projects to develop and test measures of the quality of end-of-life care for Medicare beneficiaries, and enlist quality improvement organizations and Medicare+Choice plans to implement quality improvement programs for care at the end of life.

  • Part C (Medicare Advantage)
  • Quality

June 1999 - Chapter 7

Improving care at the end of life (D)

Promote advance care planning by practitioners and patients well before terminal health crises occur.

  • Quality

June 1999 - Chapter 7

Improving the quality of care for beneficiaries with end-stage renal disease (A)

The Secretary should determine clinical criteria for dialysis patients to receive increased frequency or duration of dialysis. The Secretary should then examine the feasibility of a multitiered composite rate that would allow different payments based on the frequency and duration of dialysis prescribed, as well as other factors related to adequacy of dialysis.

  • Ambulatory care settings
  • Beneficiaries and coverage

June 1999 - Chapter 8

Improving the quality of care for beneficiaries with end-stage renal disease (B)

MedPAC reiterates the recommendation made in its March 1998 and March 1999 reports calling for an increase in the composite rate.

  • Ambulatory care settings

June 1999 - Chapter 8

Improving the quality of care for beneficiaries with end-stage renal disease (C)

The Secretary should determine clinical criteria for ESRD patients to be eligible for oral, enteral, or parenteral nutritional supplements. Coverage for these supplements should then be provided to eligible ESRD patients as a renal benefit apart from the composite rate.

  • Ambulatory care settings
  • Beneficiaries and coverage

June 1999 - Chapter 8